236 related articles for article (PubMed ID: 20542126)
1. Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats.
Xiong N; Cao X; Zhang Z; Huang J; Chen C; Zhang Z; Jia M; Xiong J; Liang Z; Sun S; Lin Z; Wang T
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1519-29. PubMed ID: 20542126
[TBL] [Abstract][Full Text] [Related]
2. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
[TBL] [Abstract][Full Text] [Related]
3. NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats.
Shang AJ; Hong SQ; Xu Q; Wang HY; Yang Y; Wang ZF; Xu BN; Jiang XD; Xu RX
Brain Res; 2011 May; 1391():102-13. PubMed ID: 21420392
[TBL] [Abstract][Full Text] [Related]
4. Environmental cue-dependent dopaminergic neuronal differentiation and functional effect of grafted neuroepithelial stem cells in parkinsonian brain.
Mine Y; Hayashi T; Yamada M; Okano H; Kawase T
Neurosurgery; 2009 Oct; 65(4):741-53; discussion 753. PubMed ID: 19834380
[TBL] [Abstract][Full Text] [Related]
5. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.
Weiss ML; Medicetty S; Bledsoe AR; Rachakatla RS; Choi M; Merchav S; Luo Y; Rao MS; Velagaleti G; Troyer D
Stem Cells; 2006 Mar; 24(3):781-92. PubMed ID: 16223852
[TBL] [Abstract][Full Text] [Related]
6. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
[TBL] [Abstract][Full Text] [Related]
7. Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells.
Hu SL; Luo HS; Li JT; Xia YZ; Li L; Zhang LJ; Meng H; Cui GY; Chen Z; Wu N; Lin JK; Zhu G; Feng H
Crit Care Med; 2010 Nov; 38(11):2181-9. PubMed ID: 20711072
[TBL] [Abstract][Full Text] [Related]
8. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease.
Xiong N; Zhang Z; Huang J; Chen C; Zhang Z; Jia M; Xiong J; Liu X; Wang F; Cao X; Liang Z; Sun S; Lin Z; Wang T
Gene Ther; 2011 Apr; 18(4):394-402. PubMed ID: 21107440
[TBL] [Abstract][Full Text] [Related]
9. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism.
Fu YS; Cheng YC; Lin MY; Cheng H; Chu PM; Chou SC; Shih YH; Ko MH; Sung MS
Stem Cells; 2006 Jan; 24(1):115-24. PubMed ID: 16099997
[TBL] [Abstract][Full Text] [Related]
10. Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.
Falkenstein G; Rosenthal C; Reum T; Morgenstern R; Döbrössy M; Nikkhah G
J Comp Neurol; 2009 Jul; 515(1):41-55. PubMed ID: 19399892
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effect of human amniotic epithelial cell transplantation into the lateral ventricle of hemiparkinsonian rats.
Yang XX; Xue SR; Dong WL; Kong Y
Chin Med J (Engl); 2009 Oct; 122(20):2449-54. PubMed ID: 20079158
[TBL] [Abstract][Full Text] [Related]
12. A high-efficiency induction of dopaminergic cells from human umbilical mesenchymal stem cells for the treatment of hemiparkinsonian rats.
Ko TL; Fu YY; Shih YH; Lin YH; Ko MH; Fu TW; Lin TY; Hsiao HS; Chu PM; Fu YS
Cell Transplant; 2015; 24(11):2251-62. PubMed ID: 25289862
[TBL] [Abstract][Full Text] [Related]
13. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.
Cova L; Armentero MT; Zennaro E; Calzarossa C; Bossolasco P; Busca G; Lambertenghi Deliliers G; Polli E; Nappi G; Silani V; Blandini F
Brain Res; 2010 Jan; 1311():12-27. PubMed ID: 19945443
[TBL] [Abstract][Full Text] [Related]
14. Rat mesenchymal stem cells increase tyrosine hydroxylase expression and dopamine content in ventral mesencephalic cells in vitro.
Jin GZ; Cho SJ; Choi EG; Lee YS; Yu XF; Choi KS; Yee ST; Jeon JT; Kim MO; Kong IK
Cell Biol Int; 2008 Nov; 32(11):1433-8. PubMed ID: 18778785
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
[TBL] [Abstract][Full Text] [Related]
16. Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents.
Hellmann MA; Panet H; Barhum Y; Melamed E; Offen D
Neurosci Lett; 2006 Mar; 395(2):124-8. PubMed ID: 16359791
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.
Blandini F; Cova L; Armentero MT; Zennaro E; Levandis G; Bossolasco P; Calzarossa C; Mellone M; Giuseppe B; Deliliers GL; Polli E; Nappi G; Silani V
Cell Transplant; 2010; 19(2):203-17. PubMed ID: 19906332
[TBL] [Abstract][Full Text] [Related]
18. Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats.
Koh SH; Kim KS; Choi MR; Jung KH; Park KS; Chai YG; Roh W; Hwang SJ; Ko HJ; Huh YM; Kim HT; Kim SH
Brain Res; 2008 Sep; 1229():233-48. PubMed ID: 18634757
[TBL] [Abstract][Full Text] [Related]
19. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
20. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
